Metformin in patients with hepatocellular carcinoma receiving immunotherapy

J Hepatol. 2023 May;78(5):e180-e182. doi: 10.1016/j.jhep.2022.12.011. Epub 2022 Dec 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Immunotherapy
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Metformin* / therapeutic use

Substances

  • Metformin
  • Hypoglycemic Agents